Enhancing the immune effect of oHSV-1 therapy through TLR3 signaling in uveal melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhancing the immune effect of oHSV-1 therapy through TLR3 signaling in uveal melanoma

Published:2022-08-28 Issue:2 Volume:149 Page:901-912
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Liu Sisi,Li Mingxin,Sun Fengqiao,Zhang Junwen,Liu Fusheng

Funder

Natural Science Foundation of Beijing Municipality

Beijing Natural Science Foundation Program and Scientific Research Key Program of the Beijing Municipal Commission of Education

Capital’s Funds for Health Improvement and Research

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-022-04272-y.pdf

Reference45 articles.

1. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413(6857):732–738. https://doi.org/10.1038/35099560

2. Amici C, Belardo G, Rossi A, Santoro MG (2001) Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy. J Biol Chem 276(31):28759–28766. https://doi.org/10.1074/jbc.M103408200

3. Bakalian S, Marshall JC, Logan P et al (2008) Molecular pathways mediating liver metastasis in patients with uveal melanoma. Clin Cancer Res 14(4):951–956. https://doi.org/10.1158/1078-0432.CCR-06-2630

4. Bonnet MC, Weil R, Dam E, Hovanessian AG, Meurs EF (2000) PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex. Mol Cell Biol 20(13):4532–4542. https://doi.org/10.1128/MCB.20.13.4532-4542.2000

5. Buder K, Gesierich A, Gelbrich G, Goebeler M (2013) Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives. Cancer Med 2(5):674–686. https://doi.org/10.1002/cam4.133

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Future of Checkpoint Inhibitors in Uveal Melanoma: A Narrative Review;Ophthalmology and Therapy;2024-03-18

2. Oncolytic Adenovirus, a New Treatment Strategy for Prostate Cancer;Biomedicines;2022-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3